Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Nicole Massoll

Concepts (246)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
9
2022
112
1.320
Why?
Thyroid Nodule
5
2022
31
1.180
Why?
Carcinoma, Papillary
4
2017
49
0.670
Why?
Biopsy, Fine-Needle
7
2024
108
0.620
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2008
60
0.530
Why?
Uterus
2
2008
87
0.530
Why?
Papillomavirus Infections
2
2008
167
0.470
Why?
Breast Neoplasms
7
2018
1183
0.390
Why?
Vulvar Neoplasms
3
2008
58
0.360
Why?
Carcinoma, Squamous Cell
4
2008
330
0.350
Why?
Cysts
2
2006
51
0.330
Why?
MicroRNAs
3
2022
347
0.330
Why?
Uterine Cervical Neoplasms
2
2008
276
0.300
Why?
Uterine Cervical Dysplasia
1
2008
49
0.300
Why?
Precancerous Conditions
1
2008
83
0.290
Why?
Carcinoma, Lobular
1
2007
33
0.280
Why?
Cytological Techniques
1
2006
14
0.270
Why?
Carcinoma, Ductal, Breast
1
2007
90
0.270
Why?
Adenomyoma
1
2005
2
0.260
Why?
Neoplasms, Hormone-Dependent
1
2005
8
0.260
Why?
Carcinoma in Situ
2
2008
73
0.250
Why?
Gynecologic Surgical Procedures
1
2005
28
0.250
Why?
Biopsy, Needle
1
2006
182
0.250
Why?
Focal Adhesion Protein-Tyrosine Kinases
3
2010
20
0.250
Why?
Uterine Neoplasms
1
2005
60
0.250
Why?
Lymph Nodes
3
2017
257
0.250
Why?
Competency-Based Education
1
2024
28
0.240
Why?
Carcinoma, Medullary
1
2004
12
0.230
Why?
Humans
34
2024
49898
0.220
Why?
Fellowships and Scholarships
1
2024
118
0.220
Why?
Adenocarcinoma, Follicular
1
2002
4
0.210
Why?
Mastectomy
2
2018
141
0.210
Why?
Thyrotropin
1
2002
47
0.210
Why?
Clinical Competence
1
2024
395
0.190
Why?
Pathology
3
2024
38
0.190
Why?
Female
21
2020
26560
0.180
Why?
Focal Adhesion Kinase 1
2
2012
15
0.180
Why?
Diagnostic Tests, Routine
1
2020
28
0.180
Why?
Carcinoma, Neuroendocrine
1
2020
23
0.180
Why?
Diagnosis, Differential
4
2008
1036
0.180
Why?
Mutation
6
2022
1292
0.170
Why?
Lung Neoplasms
2
2015
600
0.170
Why?
DNA, Neoplasm
2
2018
145
0.160
Why?
Protein Kinase Inhibitors
2
2012
205
0.160
Why?
Proto-Oncogene Proteins B-raf
2
2017
78
0.160
Why?
Immunohistochemistry
6
2015
972
0.150
Why?
Thyroid Gland
3
2020
73
0.140
Why?
Middle Aged
11
2020
12285
0.140
Why?
Pancreatic Neoplasms
2
2010
209
0.140
Why?
Gene Silencing
2
2008
114
0.140
Why?
Neoplasm Invasiveness
5
2015
268
0.140
Why?
DNA, Viral
2
2008
133
0.130
Why?
Sensitivity and Specificity
4
2020
858
0.130
Why?
PTEN Phosphohydrolase
1
2016
53
0.130
Why?
Pulmonary Medicine
1
2015
15
0.130
Why?
Fibroblasts
2
2016
352
0.130
Why?
Cytodiagnosis
1
2015
42
0.130
Why?
Aged, 80 and over
6
2020
3136
0.120
Why?
Adult
10
2020
13346
0.120
Why?
Cell Proliferation
4
2016
986
0.120
Why?
Endosonography
1
2015
94
0.120
Why?
Granuloma
2
2007
45
0.120
Why?
Lymphatic Metastasis
3
2017
226
0.120
Why?
Receptor, erbB-2
2
2018
74
0.110
Why?
Laryngeal Diseases
1
2013
12
0.110
Why?
Herpes Simplex
1
2013
21
0.110
Why?
Laryngectomy
1
2013
27
0.100
Why?
Purine Nucleosides
1
2012
3
0.100
Why?
Receptor, IGF Type 1
1
2012
20
0.100
Why?
Immunoenzyme Techniques
2
2008
141
0.090
Why?
Cell Movement
2
2009
245
0.090
Why?
Predictive Value of Tests
2
2020
907
0.090
Why?
Receptors, Somatomedin
1
2010
8
0.090
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
5
0.080
Why?
Tissue Fixation
2
2020
36
0.080
Why?
Retrospective Studies
5
2022
6123
0.080
Why?
Aniline Compounds
1
2009
42
0.080
Why?
Melanoma
1
2012
281
0.080
Why?
Promoter Regions, Genetic
2
2008
467
0.080
Why?
Aged
6
2020
9447
0.080
Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.080
Why?
Neuroblastoma
1
2008
52
0.080
Why?
Transglutaminases
1
2008
15
0.080
Why?
Proto-Oncogene Proteins c-met
1
2007
19
0.070
Why?
Mastitis
1
2007
3
0.070
Why?
Biopsy
2
2007
591
0.070
Why?
Genetic Markers
1
2008
103
0.070
Why?
GTP-Binding Proteins
1
2008
93
0.070
Why?
Genes, erbB-2
1
2007
8
0.070
Why?
Prednisone
1
2007
100
0.070
Why?
Gene Expression Regulation, Enzymologic
1
2008
178
0.070
Why?
Group Practice
1
2006
3
0.070
Why?
Intracellular Signaling Peptides and Proteins
1
2007
139
0.070
Why?
Cystatins
1
2006
1
0.070
Why?
Cadherins
1
2007
64
0.070
Why?
Frozen Sections
1
2006
13
0.070
Why?
Specialization
1
2006
46
0.070
Why?
Genomic Instability
1
2007
91
0.070
Why?
Colonic Neoplasms
1
2008
158
0.070
Why?
Tumor Suppressor Protein p53
1
2008
213
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
579
0.070
Why?
Polymerase Chain Reaction
2
2005
456
0.070
Why?
Mice
6
2017
5658
0.070
Why?
Medicine
1
2006
56
0.070
Why?
Nuclear Proteins
1
2007
242
0.070
Why?
RNA, Small Interfering
3
2012
210
0.070
Why?
Carrier Proteins
1
2007
302
0.060
Why?
Antigens, CD
1
2007
215
0.060
Why?
Mullerian Ducts
1
2005
4
0.060
Why?
Gene Expression
1
2008
612
0.060
Why?
Fallopian Tubes
1
2005
22
0.060
Why?
Medical Oncology
1
2006
95
0.060
Why?
Signal Transduction
1
2012
1608
0.060
Why?
Estrogen Replacement Therapy
1
2005
28
0.060
Why?
Vulva
1
2005
17
0.060
Why?
Data Collection
1
2006
282
0.060
Why?
ABO Blood-Group System
1
2005
15
0.060
Why?
Chromosome Aberrations
1
2007
295
0.060
Why?
Ovariectomy
1
2005
113
0.060
Why?
Glucocorticoids
1
2007
229
0.060
Why?
Hysterectomy
1
2005
88
0.060
Why?
Decision Making
1
2007
273
0.060
Why?
Mice, Nude
3
2010
252
0.060
Why?
Regression Analysis
1
2006
385
0.060
Why?
Carcinoma, Transitional Cell
1
2005
52
0.060
Why?
Epithelial Cells
1
2006
209
0.060
Why?
Male
7
2020
25437
0.060
Why?
Papillomaviridae
1
2005
102
0.060
Why?
Cell Survival
3
2012
590
0.060
Why?
Epigenesis, Genetic
1
2008
370
0.060
Why?
Cell Line, Tumor
4
2009
1388
0.060
Why?
Cohort Studies
2
2020
1403
0.060
Why?
Ultrasonography
1
2006
429
0.060
Why?
Prospective Studies
2
2022
2345
0.050
Why?
Base Sequence
3
2010
657
0.050
Why?
Gene Expression Regulation
1
2007
964
0.050
Why?
Education, Medical, Graduate
1
2024
211
0.050
Why?
Thyroidectomy
1
2002
59
0.050
Why?
Gene Expression Profiling
1
2007
1028
0.050
Why?
Adolescent
3
2015
6414
0.050
Why?
Yersinia pseudotuberculosis
1
2001
4
0.050
Why?
Animals
6
2017
13100
0.050
Why?
Yersinia Infections
1
2001
6
0.050
Why?
Yersinia enterocolitica
1
2001
6
0.050
Why?
Recombinant Proteins
1
2002
482
0.050
Why?
Combined Modality Therapy
1
2002
638
0.050
Why?
Formaldehyde
1
2020
50
0.040
Why?
Oncogenes
1
2020
57
0.040
Why?
Appendicitis
1
2001
62
0.040
Why?
Disease Progression
3
2008
820
0.040
Why?
Cell Differentiation
1
2002
649
0.040
Why?
Neoplasm Staging
2
2015
749
0.040
Why?
Transplantation, Heterologous
2
2010
75
0.040
Why?
Toxicology
1
1999
29
0.040
Why?
Antineoplastic Agents
1
2008
1175
0.040
Why?
Blotting, Western
2
2012
587
0.040
Why?
DNA Methylation
3
2008
544
0.040
Why?
DNA Primers
2
2010
208
0.040
Why?
Young Adult
2
2020
4029
0.040
Why?
Paraffin Embedding
1
2018
52
0.040
Why?
Specimen Handling
1
2018
54
0.040
Why?
Receptors, Progesterone
1
2018
63
0.040
Why?
Receptors, Estrogen
1
2018
130
0.040
Why?
Lymphatic System
1
2017
13
0.040
Why?
Methylene Blue
1
2017
10
0.040
Why?
Animals, Genetically Modified
1
2017
48
0.040
Why?
Coloring Agents
1
2017
67
0.040
Why?
Mice, Inbred Strains
1
2017
160
0.030
Why?
Prognosis
2
2015
1956
0.030
Why?
Follow-Up Studies
2
2015
2175
0.030
Why?
Treatment Outcome
1
2006
5176
0.030
Why?
Cost Savings
1
2015
58
0.030
Why?
Apoptosis
2
2012
1092
0.030
Why?
Mice, Knockout
2
2008
835
0.030
Why?
Neoplasm Grading
1
2015
123
0.030
Why?
RNA, Messenger
2
2008
1099
0.030
Why?
Collagen
1
2016
208
0.030
Why?
Cost-Benefit Analysis
1
2015
269
0.030
Why?
Tumor Microenvironment
1
2016
221
0.030
Why?
Immunoprecipitation
1
2012
58
0.030
Why?
In Situ Nick-End Labeling
1
2012
52
0.030
Why?
Flow Cytometry
1
2012
470
0.020
Why?
Staurosporine
1
2009
12
0.020
Why?
Cell Line
1
2012
1010
0.020
Why?
Deoxycytidine
1
2009
28
0.020
Why?
Drug Synergism
1
2009
152
0.020
Why?
Cell Adhesion
1
2009
155
0.020
Why?
RNA Interference
1
2009
178
0.020
Why?
Xenograft Model Antitumor Assays
1
2009
212
0.020
Why?
Polymorphism, Single-Stranded Conformational
1
2008
19
0.020
Why?
Chromatin Immunoprecipitation
1
2008
48
0.020
Why?
Luciferases
1
2008
50
0.020
Why?
Adenoviridae
1
2008
49
0.020
Why?
Florida
1
2008
57
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
67
0.020
Why?
Fluorouracil
1
2008
55
0.020
Why?
Loss of Heterozygosity
1
2008
77
0.020
Why?
Histone Deacetylase 2
1
2007
4
0.020
Why?
Electrophoresis, Polyacrylamide Gel
1
2008
102
0.020
Why?
Phosphorylation
1
2009
526
0.020
Why?
Transcriptional Activation
1
2008
121
0.020
Why?
Co-Repressor Proteins
1
2007
18
0.020
Why?
Estrogens
1
2009
222
0.020
Why?
Sequence Deletion
1
2007
69
0.020
Why?
Drug Screening Assays, Antitumor
1
2008
131
0.020
Why?
Transfection
1
2008
354
0.020
Why?
Molecular Chaperones
1
2007
63
0.020
Why?
Histone Deacetylases
1
2007
49
0.020
Why?
Enzyme Inhibitors
1
2009
378
0.020
Why?
Ultrasonography, Mammary
1
2007
61
0.020
Why?
Kaplan-Meier Estimate
1
2008
463
0.020
Why?
Chromatin
1
2007
137
0.020
Why?
Tumor Cells, Cultured
1
2007
462
0.020
Why?
Transcription, Genetic
1
2008
370
0.020
Why?
Cystatin M
1
2006
19
0.020
Why?
Molecular Sequence Data
1
2008
799
0.020
Why?
5' Untranslated Regions
1
2006
31
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Repressor Proteins
1
2007
149
0.020
Why?
Down-Regulation
1
2007
342
0.020
Why?
Carcinoma
1
2007
139
0.020
Why?
Wound Healing
1
2007
201
0.020
Why?
Cesarean Section
1
2007
159
0.020
Why?
Protein Binding
1
2007
656
0.020
Why?
Survival Rate
1
2008
905
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2009
824
0.020
Why?
Chi-Square Distribution
1
2005
275
0.010
Why?
Cells, Cultured
1
2008
1587
0.010
Why?
Neoplasm Recurrence, Local
1
2008
626
0.010
Why?
Pregnancy Complications
1
2007
363
0.010
Why?
Child
2
2008
6844
0.010
Why?
Tomography, X-Ray Computed
1
2007
1150
0.010
Why?
Appendix
1
2001
23
0.010
Why?
Infant, Newborn
1
2008
2729
0.010
Why?
DNA, Bacterial
1
2001
187
0.010
Why?
Magnetic Resonance Imaging
1
2007
1525
0.010
Why?
Pregnancy
1
2007
2468
0.010
Why?
Environmental Medicine
1
1999
1
0.010
Why?
Occupational Medicine
1
1999
4
0.010
Why?
History, Ancient
1
1999
9
0.010
Why?
Forensic Medicine
1
1999
7
0.010
Why?
History, 19th Century
1
1999
22
0.010
Why?
Infant
1
2008
3572
0.010
Why?
Risk Factors
1
2008
3604
0.010
Why?
Child, Preschool
1
2008
3875
0.010
Why?
History, 20th Century
1
1999
95
0.010
Why?
Massoll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description